Finance

Lists
Why is MLAB up 2.09%?
Dive Deeper
MLAB:NASDAQ
Mesa Laboratories Inc
$134.63
+2.09%
(+2.76) 1D
$134.63
0.00% (0.00)
After hours
Closed: Sep 22, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MLAB...
Open
$130.99
High
$136.20
Low
$130.68
Mkt. cap
753.37M
Avg. vol.
157.17K
Volume
114.66K
Dividend
0.48%
Quarterly dividend
$0.16
Ex-dividend date
Aug 31, 2026
P/E ratio
159.29
52-wk high
$136.20
52-wk low
$63.48
EPS
$0.85
Beta
0.97
Shares outstanding
5.60M
No. of employees
717
Open
$130.99
High
$136.20
Low
$130.68
Mkt. cap
753.37M
Avg. vol.
157.17K
Volume
114.66K
Dividend
0.48%
Quarterly dividend
$0.16
Ex-dividend date
Aug 31, 2026
P/E ratio
159.29
52-wk high
$136.20
52-wk low
$63.48
EPS
$0.85
Beta
0.97
Shares outstanding
5.60M
No. of employees
717
News stories
From web sources and news partners
About Mesa Laboratories Inc
CEO-
Employees717
Founded1982
HeadquartersLakewood, Colorado, United States
SectorHealth care
Websitemesalabs.com
Analyst ratings
Based on 1 analyst giving stock ratings to MLAB in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for MLAB in the last 3 months
Highest
Current $134.63
$110.00 (-18.29%)
Average
$110.00 (-18.29%)
Lowest
$110.00 (-18.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Evan Stampler
Wells Fargo
Hold
Reiterated
$110.00
-18.3%
08/14/2026
Brandon Couillard
Wells Fargo
Hold
Reiterated
$110.00
-18.3%
08/14/2026
Tycho Peterson
Jefferies
Buy
Maintained
$115.00
-14.6%
03/11/2026
Last report
Aug 10, 2026
Fiscal period
Q1 2027
EPS / Est. (USD)
$1.30 / $2.55
-49.13%miss
Revenue / Est. (USD)
60.14M / 60.87M
-1.20%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
60.74M
65.13M
63.72M
60.14M
Cost of goods sold
23.41M
23.33M
21.52M
21.13M
Cost of revenue
23.41M
23.33M
21.52M
21.13M
Research and development expenses
5.05M
5.03M
5.25M
4.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.56M
28.79M
34.21M
27.26M
Operating expense
32.61M
33.82M
39.46M
31.98M
Total operating expenses
56.01M
57.15M
60.98M
53.11M
Operating income
4.72M
7.98M
2.75M
7.03M
Other non operating income
137.00K
-
4.06M
-
EBT including unusual items
2.00M
4.60M
-1.59M
4.35M
EBT excluding unusual items
2.00M
4.60M
-1.59M
4.35M
Income tax expense
-477.00K
966.00K
2.54M
1.52M
Effective tax rate
-23.86%
21.02%
-159.64%
34.99%
Other operating expenses
-
-
-
-
Net income
2.48M
3.63M
-4.14M
2.83M
Net profit margin
4.08%
5.57%
-6.49%
4.71%
Earnings per share
2.11
1.76
1.83
1.30
Interest and investment income
-
-
-
-
Interest expense
-2.86M
-3.04M
-2.60M
-2.36M
Net interest expenses
-2.86M
-3.04M
-2.60M
-2.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
10.57M
13.69M
8.50M
12.68M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps